Adicet Bio, Inc. — Director's Dealing 2021

Jan 15, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Adicet Bio, Inc. (ACET)
CIK: 0001720580
Period of Report: 2021-01-13

Reporting Person: Harvey Brian Nicholas (Chief Financial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-01-13	Stock Option (Right to Buy)	$13.27	A	90000	Acquired	2031-01-12	Common Stock (90000)	Direct

Footnotes

F1: 25% of the shares shall vest on the first anniversary of the Vesting Start Date and, thereafter, the remainder of the shares shall vest in 36 equal monthly installments, provided that the Reporting Person maintains a service relationship with the Company.